ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Comparative Profiling of the Novel Epothilone, Sagopilone, in Xenografts Derived from Primary Non–Small Cell Lung Cancer
Clinical Cancer Research
◽
10.1158/1078-0432.ccr-09-2455
◽
2010
◽
Vol 16
(5)
◽
pp. 1452-1465
◽
Cited By ~ 30
Author(s):
Stefanie Hammer
◽
Anette Sommer
◽
Iduna Fichtner
◽
Michael Becker
◽
Jana Rolff
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
The Novel
◽
Small Cell Lung
Download Full-text
Related Documents
Cited By
References
Abstract 4818: Fc-mediated mechanism of action for the novel EGFR-cMET bispecific antibody (JNJ-61186372) in non-small cell lung cancer
10.1158/1538-7445.sabcs18-4818
◽
2019
◽
Author(s):
Smruthi Vijayaraghavan
◽
Barbara Bushey
◽
Lorriane Lipfert
◽
Rupesh Nanjunda
◽
Eilyn R. Lacy
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Mechanism Of Action
◽
Cell Lung Cancer
◽
Bispecific Antibody
◽
Small Cell
◽
The Novel
◽
Small Cell Lung
Download Full-text
The novel dual PI3K/mTOR inhibitor GDC-0941 synergizes with the MEK inhibitor U0126 in non-small cell lung cancer cells
Molecular Medicine Reports
◽
10.3892/mmr.2011.682
◽
2011
◽
Cited By ~ 1
Author(s):
Xiao-Hong Zhang
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cancer Cells
◽
Cell Lung Cancer
◽
Mtor Inhibitor
◽
Mek Inhibitor
◽
Small Cell
◽
Lung Cancer Cells
◽
The Novel
◽
Small Cell Lung
Download Full-text
Improved event free survival (EFS) with the novel retinoid, bexarotene (BEX) and gemcitabine/carboplatin (G/C) in non-small cell lung cancer (NSCLC)
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.7104
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7104-7104
Author(s):
M. J. Edelman
◽
J. Kendall
◽
R. Smith
◽
P. F. Hausner
◽
K. Kalra
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Small Cell
◽
The Novel
◽
Event Free Survival
◽
Small Cell Lung
◽
Free Survival
Download Full-text
A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: A study of the EORTC Early Clinical Studies Group (ECSG)
Annals of Oncology
◽
10.1093/oxfordjournals.annonc.a010645
◽
1996
◽
Vol 7
(5)
◽
pp. 529-531
◽
Cited By ~ 33
Author(s):
N. Pavlidis
◽
A.R. Hanauske
◽
T. Gamucci
◽
J. Smyth
◽
M. Lehnert
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Clinical Studies
◽
Phase Ii Study
◽
Small Cell
◽
The Novel
◽
Small Cell Lung
◽
Randomized Phase Ii
Download Full-text
Phase II study of the combination of the novel bioreductive agent, tirapazamine, with cisplatin in patients with advanced non-small-cell lung cancer
Annals of Oncology
◽
10.1023/a:1008219125746
◽
1997
◽
Vol 8
(12)
◽
pp. 1269-1271
◽
Cited By ~ 29
Author(s):
V.A. Miller
◽
K.K. Ng
◽
S.C. Grant
◽
H. Kindler
◽
B. Pizzo
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Phase Ii Study
◽
Small Cell
◽
The Novel
◽
Small Cell Lung
Download Full-text
Abstract P079: The impact of BCL2 expression on sensitivity to the novel Aurora kinase B inhibitor AZD2811 in small cell lung cancer
10.1158/1535-7163.targ-21-p079
◽
2021
◽
Author(s):
Azusa Tanimoto
◽
Carminia M. Della Corte
◽
Kavya Ramkumar
◽
Robert J. Cardnell
◽
Allison C. Stewart
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Aurora Kinase
◽
Small Cell
◽
The Novel
◽
Small Cell Lung
◽
Aurora Kinase B
◽
The Impact
◽
Bcl2 Expression
Download Full-text
Abstract 590: Antiproliferative effects and signaling profiles of the novel HSP90 inhibitor NVP-AUY922 in non-small cell lung cancer
10.1158/1538-7445.am2011-590
◽
2011
◽
Author(s):
Tsuyoshi Ueno
◽
Shinichi Toyooka
◽
Kazunori Tsukuda
◽
Takaoka Munenori
◽
Junichi Soh
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Hsp90 Inhibitor
◽
Small Cell
◽
The Novel
◽
Small Cell Lung
◽
Antiproliferative Effects
Download Full-text
Abstract 4818: Fc-mediated mechanism of action for the novel EGFR-cMET bispecific antibody (JNJ-61186372) in non-small cell lung cancer
10.1158/1538-7445.am2019-4818
◽
2019
◽
Author(s):
Smruthi Vijayaraghavan
◽
Barbara Bushey
◽
Lorriane Lipfert
◽
Rupesh Nanjunda
◽
Eilyn R. Lacy
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Mechanism Of Action
◽
Cell Lung Cancer
◽
Bispecific Antibody
◽
Small Cell
◽
The Novel
◽
Small Cell Lung
Download Full-text
The novel PI3K inhibitor S1 synergizes with sorafenib in non-small cell lung cancer cells involving the Akt-S6 signaling
Investigational New Drugs
◽
10.1007/s10637-018-0698-2
◽
2018
◽
Vol 37
(5)
◽
pp. 828-836
◽
Cited By ~ 3
Author(s):
Juan Wang
◽
Shumei Ma
◽
Xiuhua Chen
◽
Sanqi Zhang
◽
Zhiyong Wang
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cancer Cells
◽
Cell Lung Cancer
◽
Small Cell
◽
Pi3k Inhibitor
◽
Lung Cancer Cells
◽
The Novel
◽
Small Cell Lung
Download Full-text
The novel lncRNA PTTG3P is downregulated and predicts poor prognosis in non-small cell lung cancer
Archives of Medical Science
◽
10.5114/aoms.2020.93535
◽
2020
◽
Vol 16
(4)
◽
pp. 931-940
Author(s):
Hai-Tao Huang
◽
Yi-Ming Xu
◽
Sheng-Guang Ding
◽
Xiao-Qiang Yu
◽
Fei Wang
◽
...
Keyword(s):
Lung Cancer
◽
Small Cell Lung Cancer
◽
Cell Lung Cancer
◽
Poor Prognosis
◽
Small Cell
◽
The Novel
◽
Small Cell Lung
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close